SCHEMBL9532807

SCHEMBL9532807

C[CH]CC(C)CCC(C)C

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7560931 0.83 LMNA (0.57) LMNA
SCHEMBL28445894 0.78
SCHEMBL2398503 0.77
SCHEMBL56450 0.77
SCHEMBL293753 0.74
SCHEMBL338932 0.74
SCHEMBL1784169 0.74 LMNA (0.33) LMNA
SCHEMBL1903210 0.74 MEN1 (0.33) LMNA
SCHEMBL9438275 0.74 LMNA (0.46) LMNA
SCHEMBL20610035 0.73 LMNA (0.56) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed